Home / Research and experimental development on biotechnology (except medical and veterinary science)

MILESTONE PHARMA SINGAPORE PTE. LTD.

Live CompanyUEN 202605234DLocal Company

MILESTONE PHARMA SINGAPORE PTE. LTD. is a local company in Singapore with UEN 202605234D. It was registered on 2 Feb 2026. Its status is Live Company. Its main activity is research and experimental development on biotechnology (except medical and veterinary science).

UEN202605234D
StatusLive Company
Entity typeLocal Company, Private Company Limited by Shares
Registered2 Feb 2026
Main activity (SSIC)72101 Research and experimental development on biotechnology (except medical and veterinary science)
Secondary activity71200 Technical testing and analysis services; certification of products and services
Address20 CECIL STREET, #05-03, PLUS, Singapore 049705
1100 companies at this address
AreaDowntown Core · District 1 (Raffles Place, Cecil, Marina, People's Park)
Nearest stationRaffles Place MRT, about 79 m
Officers4

Newer companies in research and experimental development on biotechnology (except medical and veterinary science)

  • DAYOU BIOTECHNOLOGY PTE. LTD.202637714W · 18 Aug 2026 · Research and experimental development on biotechnology (except medical and veterinary science)
  • PROBIO TECHNOLOGY PRIVATE LIMITED202636974G · 13 Aug 2026 · Research and experimental development on biotechnology (except medical and veterinary science)
  • NEUTHERA PTE. LTD.202636842M · 12 Aug 2026 · Research and experimental development on biotechnology (except medical and veterinary science)
  • PC BIOME INNOVATIONS PTE. LTD.202636514M · 11 Aug 2026 · Research and experimental development on biotechnology (except medical and veterinary science)
  • THERALIFE53529115M · 1 Aug 2026 · Research and experimental development on biotechnology (except medical and veterinary science)
  • BIO-SUPPLY INNOVATIONS PTE. LTD.202633668E · 24 Jul 2026 · Research and experimental development on biotechnology (except medical and veterinary science)

Source: ACRA open data, data date 16 Sep 2026. Directors, shareholders and financial statements are not in the open data.